Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Techniques in Coloproctology
Published in: Techniques in Coloproctology 3/2017

01-03-2017 | Controversies in Colorectal Surgery

Rectal cancer should not be resected laparoscopically: the rationale and the data

Authors: S. K. Abbas, S. B. Yelika, K. You, J. Mathai, R. Essani, Z. Krivokapić, R. Bergamaschi

Published in: Techniques in Coloproctology | Issue 3/2017

Login to get access

Excerpt

In 2006, the Cochrane Review [1] had identified 48 articles describing laparoscopic resection for rectal cancer, although only three of those studies were randomized controlled trials (RCTs) accounting for over 600 patients. These RCTs did not comply with the CONSORT statement [2] on allocation concealment. Two of the trials provided no data on the distance of the cancer from the anal verge [3, 4]; hence, it is possible that these trials included rectosigmoid cancers. The CLASICC RCT [5] provided the only credible source of truly randomized data on laparoscopic resection for rectal cancer at that time. Although not reaching statistical significance (p = 0.19), the involvement of the circumferential resection margin (CRM) was doubled in the laparoscopic arm as compared to its open counterpart, 12 versus 6%. In the following years, four non-inferiority RCTs comparing laparoscopic to open resection for rectal cancer were launched with the following composite endpoints: CRM, distal margin, total mesorectal excision (TME) quality, local recurrence and 3-year survival. …
Literature
1.
Breukink S, Pierie J, Wiggers T (2006) Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev 4. Art. No.: CD005200
2.
Moher D, Schulz KF, Altman DG, for the CONSORT Group (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134:657–662CrossRef
3.
Leung KL, Lai PB, Ho RLK, Meng WCS, Yiu RYC, Lee JFY et al (2000) Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial. Ann Surg 231:506–511CrossRefPubMedPubMedCentral
4.
Leung KL, Kwok SPY, Lam SCW, Lee JF, Yiu RY, Ng SS et al (2004) Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 363:1187–1192CrossRefPubMed
5.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, et. al., for the MRC CLASICC trial group (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365(9472):1718–1726CrossRef
6.
Barnajian M, Pettet D 3rd, Kazi E, Foppa C, Bergamaschi R (2014) Quality of total mesorectal excision and depth of circumferential resection margin in rectal cancer: a matched comparison of the first 20 robotic cases. Colorectal Dis 16(8):603–609CrossRefPubMed
7.
Essani R, Bergamaschi R (2016) Robotic colorectal surgery: advance or expense? Adv Surg 50(1):157–171CrossRefPubMed
8.
Bhlat OS, Haluck RS, Murray WB, Gorman PJ, Krummel TM (1999) Tactile feedback is present during minimally invasive surgery. J Am Coll Surg 189:349–355CrossRef
9.
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999CrossRefPubMed
10.
Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH (2002) Pathology review committee, cooperative clinical investigators. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357CrossRefPubMed
11.
Fleshman J, Branda B, Sargent DJ, Boller AM, George V, Abbas M et al (2015) Effect of Laparoscopic-assisted resection vs open resection of stage ii or iii rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355CrossRefPubMedPubMedCentral
12.
Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCart randomized clinical trial. JAMA 314(13):1356–1363CrossRefPubMed
13.
Bonjer JH, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES et al (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372:1324–1332CrossRefPubMed
14.
Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB et al (2014) Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 15(7):767–774CrossRefPubMed
15.
16.
Fingerhut A, Lacaine F, Cuschieri A (2015) Medical SPIN: misinformation by another name. Surg Endosc 29(6):1257–1258CrossRefPubMed
Metadata
Title
Rectal cancer should not be resected laparoscopically: the rationale and the data
Authors
S. K. Abbas
S. B. Yelika
K. You
J. Mathai
R. Essani
Z. Krivokapić
R. Bergamaschi
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Techniques in Coloproctology / Issue 3/2017
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-017-1596-x

Other articles of this Issue 3/2017

Techniques in Coloproctology 3/2017 Go to the issue

Controversies in Colorectal Surgery

Laparoscopic surgery for rectal cancer: the verdict is not final yet!

Original Article

Permacol™ collagen paste injection for the treatment of complex anal fistula: 1-year follow-up

Trick of the Trade

LBet 88: a new device for outpatient treatment of selected grade III hemorrhoids

Review

Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta-analysis

Original Article

Long-term results of transanal endoscopic microsurgery after endoscopic polypectomy of malignant rectal adenoma

Multimedia Article

Combined transanal total mesorectal excision (taTME) with laparoscopic instruments and abdominal robotic surgery in rectal cancer